Basic information Safety Supplier Related

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]-

Basic information Safety Supplier Related

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]- Basic information

Product Name:
BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]-
Synonyms:
  • BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]-
  • (±)-4-Methoxy-N-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]benzamide
  • Enkade
  • Enkaid
  • MJ-9067
  • 4-Methoxy-2'-[2-(1-methyl-3-piperidyl)ethyl]benzanilide
  • M-9067-1
  • MJ-9067[AS BASE]
CAS:
66778-36-7
MF:
C22H28N2O2
MW:
352.47
Mol File:
66778-36-7.mol
More
Less

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]- Chemical Properties

storage temp. 
Store at -20°C
form 
Solid
color 
White to off-white
More
Less

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]- Usage And Synthesis

Chemical Properties

Light yellow crystal. Soluble in ether, insoluble in saturated saline. Encainide Hydroehloride: C22H28N2O2?HCI.[66794-74-9]. White crystal, melting point 131.5-132.5℃. Soluble in water, slightly soluble in alcohol, insoluble in ether or pentane. Acute toxicity LD50 mice, dogs (mg/kg): 86, 43 oral; 16, 17 intravenous.

Uses

Encainide (MJ9067) is an antiarrhythmic agent with class IC activity. Encainide blocks voltage-dependent potassium channels. Encainide has the potential for life-threatening ventricular arrhythmias, symptomatic ventricular arrhythmias and supraventricular arrhythmias research[1][2].

Definition

ChEBI: 4-Methoxy-N-phenylbenzamide in which the hydrogen at the 2 position of the phenyl group is substituted by a 2-(1-methylpiperidin-2-yl)ethyl group. A class Ic antiarrhythmic, the hydrochloride was used for the treatment of severe or life- hreatening ventricular arrhythmias, but it was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack and was withdrawn from the market.

in vivo

Encainide (0.3, 0.9, 2.7 mg/kg; infusion of single doses) prolongs His-Purkinje conduction time (HV interval) and intra-ventricular conduction time (QRS duration) but has no effect on sinus nodal recovery time or AV nodal conduction, or on refractoriness of atrium, AV node, or ventricular myocardium or on QT interval[1].

References

[1] R N Brogden, et al. Encainide. A review of its pharmacological properties and therapeutic efficacy. Drugs. 1987 Nov;34(5):519-38. DOI:10.2165/00003495-198734050-00002
[2] Hongliang Li, et al. Encainide, a class Ic anti-arrhythmic agent, blocks voltage-dependent potassium channels in coronary artery smooth muscle cells. Korean J Physiol Pharmacol. 2023 Jul 1;27(4):399-406. DOI:10.4196/kjpp.2023.27.4.399

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]- Preparation Products And Raw materials

Raw materials

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]-Supplier

Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com
Shanghai Merlot Chemical Co., LTD
Tel
15821661757
Email
226174156@qq.com
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn
Shaanxi Xihua Chemical Industry Co., Ltd
Tel
029-81136151 17392212881
Email
1095@dideu.com
More
Less

BENZAMIDE, 4-METHOXY-N-[2-[2-(1-METHYL-2-PIPERIDINYL)ETHYL]PHENYL]-(66778-36-7)Related Product Information